White vs Green Kratom: Stimulation Claims Versus the Lab Evidence

White and green kratom are both dried leaf of Mitragyna speciosa. “White” is marketed as the most energising and focus-oriented colour, “green” as a balanced middle ground. Users in one survey did rate white as more stimulating, but the white and green products they used did not differ in measured alkaloid content, and the labels have no agreed definition.

So this comparison is really about two things: what people consistently say they feel, and what can actually be verified about the powder in the bag. The second part matters more for safety, because potency varies by batch, season and processing far more than by colour name.

This page does not give dosing advice. Kratom is not an approved medicine in the US, UK or Canada.

At a glance

Property	White kratom	Green kratom
Plant	Mitragyna speciosa leaf	Mitragyna speciosa leaf
How vendors describe it	Pale-veined or young leaves, often dried indoors	Green-veined leaves, dried indoors or in shade
Is that verified?	No published standard or audit	No published standard or audit
Main alkaloid in retail leaf	Mitragynine	Mitragynine
Alkaloids in retail testing	No significant difference from green 1	No significant difference from white 1
Users more often cite	Concentration, work, sociability	Mood
Rated for staying awake all night	Higher (about 41 of 100) 1	Lower (about 26 of 100) 1
Blinded human trials	None	None
Safety profile	Same as any kratom	Same as any kratom
Key COA figures	Mitragynine %, 7-OH, metals, microbes	Mitragynine %, 7-OH, metals, microbes

What makes kratom “white” or “green”

Retail kratom colours are named after leaf vein colour, but in practice the name usually describes the finished powder. A 2025 postharvest study noted that Western strain labels are most commonly based on powder colour rather than the actual vein colour or variety, and showed that drying conditions alone can change that colour.²

Vendors typically say white kratom comes from pale-veined or younger leaves dried indoors, sometimes in the dark, and green from green-veined leaves dried indoors or in shade. Those accounts differ from seller to seller, and we found no independent audit confirming any of them. Our white vein kratom glossary entry and wider guide to kratom strains cover the naming conventions.

The young-leaf question

The young-leaf claim is the one part of the white kratom story with a plausible chemical basis. In a 2026 study of Thai trees, mature leaves carried mitragynine as their main alkaloid (up to 1.19% of dry mass), whereas juvenile leaves carried speciociliatine as the main alkaloid (up to 1.14%).³ The same study found vein colour itself varied on a single tree with leaf age.

That matters because speciociliatine belongs to a group of kratom alkaloids that behaved differently in the body from mitragynine in a small human study, with a later peak and a shorter half-life.⁴ But nobody has shown that retail white kratom is actually made from young leaves, and when white and green retail products were tested side by side, their alkaloid content did not differ significantly.¹ For now, the young-leaf idea is a hypothesis, not a description of what you buy.

Energy and focus: what users report for white and green

The main source is a 2023 survey of 644 current kratom users, most buying from one US vendor, who rated each colour they used on 39 effect scales from 0 to 100.¹ The white versus green gaps that reached statistical significance were:

• Concentration: white about 69, green about 61.
• Feeling stimulated: white about 63, green about 53.
• Staying up all night: white about 41, green about 26.
• Constipation: white about 42, green about 26, so green was rated easier on digestion.

Other differences did not reach significance. White and green were rated almost the same for feeling energetic (about 67 and 64), and for pain, mood, calm and relaxation. When ranking reasons for use, white users put concentration, work or study and sociability highest of the three colours, while green users put mood highest.¹

Context matters when reading these numbers. Green had the most raters in the sample (288 people) and white the fewest (131). Respondents were mostly middle-aged American adults, and many reported chronic pain, depression or anxiety diagnoses, so results from this group may not carry over to other users or other vendors’ products.¹

So the user picture is fairly consistent with vendor descriptions: white as the “sharper” option, green as a gentler all-rounder. The question is whether that reflects the powder or the label.

What the evidence can and cannot tell you

The same survey had the vendor’s products analysed by an independent laboratory, and found no significant differences in alkaloid content between colours.¹ The authors suggested reported differences might be disproportionately shaped by marketing and anecdote, while noting that unmeasured minor alkaloids, terpenes or individual metabolism could also play a part.

Plant studies point the same way. Drying temperature and withering time changed mitragynine, speciogynine and paynantheine levels in ways that powder colour did not reveal: two green powders from the same leaves differed in key alkaloids depending on withering time.² Across 745 Thai leaf samples, mitragynine ranged from roughly 0.3% to 4.9% of dry weight, driven by season and region.⁵ Variation of that size makes a colour label a weak guide.

Evidence quality at a glance

• Human effects: one unblinded self-report survey, mostly one vendor’s customers. No controlled trial of white versus green exists.
• Chemistry of retail products: one small set of vendor products, no colour differences found.
• Plant science: growing and drying studies show large batch variation that does not track colour neatly.

That is thin evidence in either direction. It does not prove that white and green feel identical, but it gives no firm basis for treating them as chemically distinct products.

Safety, interactions and drug testing for white and green kratom

White and green kratom carry the same risks. The FDA warns about liver toxicity, seizures, substance use disorder, tolerance and withdrawal, and reports rare deaths, often with other substances involved.⁶ Tolerance and dependence are linked to regular use of kratom generally, not to one colour.

Because white kratom is sold for alertness, some users combine it with coffee or other stimulants. There is no research on that combination, and the survey’s higher “stay up all night” scores for white are a reason to think about sleep.¹

Medicine interactions are the better-documented concern. In a study of 12 healthy adults, one serving of kratom tea raised exposure to the CYP3A test drug midazolam by roughly 40%.⁷ Many prescription drugs share that pathway, so check with a pharmacist.

For drug testing, mitragynine is not on the standard five-drug workplace panel, but targeted tests can detect it whatever the colour. Contamination is a shared risk too: a 2017 to 2018 US Salmonella outbreak linked to kratom involved 199 cases in 41 states,⁸ and FDA testing of 30 products found lead and nickel at levels the agency judged a risk for heavy, long-term users.⁹

Reading a COA for white or green kratom

A batch-specific certificate of analysis tells you more than any colour name. Our guide to reading a kratom lab report walks through a real layout. Check these points in order:

1. Identity and batch. Product name, lot number matching your pack, test date and a named independent lab, ideally ISO/IEC 17025 accredited.
2. Mitragynine percentage. Plain leaf in Thai field studies measured roughly 0.3% to 5% of dry weight.⁵ A white or green “leaf” reporting far higher is likely an extract or fortified.
3. 7-OH. Natural leaf contains only a trace. Researchers have previously found commercial products with 7-OH levels well above those of raw leaf, suggesting adulteration.¹⁰ The DEA’s proposed line for botanical kratom is 0.050% 7-OH by dry weight.¹¹ A result given as a number, or below a stated limit of quantification, is more useful than “ND” alone.
4. Heavy metals. Numeric results for lead, arsenic, cadmium and mercury, and ideally nickel.⁹
5. Microbiology. Salmonella and E. coli not detected, plus total aerobic count and yeast and mould.

Be especially careful with white products sold as “enhanced”, “extra strength” or “premium”. Those words have no fixed meaning, and a mitragynine or 7-OH figure well above plain-leaf levels suggests the powder has been boosted with extract. Our comparison of kratom extract and powder explains why that changes the risk picture.

If a seller shows identical COAs for its white and green lines, or cannot produce one tied to your batch, that tells you something about how the colours are managed.

Legal status in September 2026

Colour has no legal meaning. Federally, kratom leaf is not a controlled substance in the US, though the FDA does not regard it as a lawful dietary supplement or food ingredient and no kratom medicine is approved.⁶

The DEA’s 2026 action targets concentrated 7-OH, not leaf. Its 6 July 2026 notice of intent proposes temporary Schedule I control of botanical kratom containing more than 0.050% 7-OH by dry weight, and of other products above 0.050% or 1 mg of 7-OH per article, with natural leaf below the line excluded.¹¹ As of 23 September 2026 that order had not been published. Mitragynine pseudoindoxyl, MGM-15 and MGM-16, derivatives of kratom alkaloids found in concentrated products, have been temporarily in Schedule I since 26 August 2026.¹² Our comparison of 7-OH and traditional kratom explains why regulators treat them differently.

States differ. Some ban kratom, many regulate it through Kratom Consumer Protection Acts with minimum ages and labelling rules, and Florida has acted by emergency rule against concentrated 7-OH. Our explainer on the Kratom Consumer Protection Act covers what those laws require.

In the UK, selling or importing kratom is prohibited under the Psychoactive Substances Act 2016; possession alone is not an offence. In Canada, kratom is not a scheduled drug, but Health Canada has not authorised the sale of any product containing it.

Frequently asked questions

Is white kratom more energising than green kratom?

Users say so. In a 2023 survey, white was rated more stimulating than green and better for concentration and staying up late, though ratings for feeling energetic were almost identical.¹ The same study found no significant alkaloid differences between the white and green products tested, so the gap may reflect expectation as much as chemistry. No controlled trial has compared them.

Is white kratom made from young leaves?

Some vendors say so, but it has not been verified for retail products. Plant research shows young kratom leaves can have a different main alkaloid, speciociliatine, than mature leaves, which are dominated by mitragynine.³ Whether white kratom on sale actually comes from young leaves is unknown, and tested retail white and green products did not differ in alkaloid content.¹

Is green kratom a mix of white and red?

Not as a rule. Green is sold as its own colour, usually described as green-veined leaf dried indoors or in shade. Some vendors do sell blends labelled with more than one colour, and those should say so on the pack. Because colour labels are not standardised, the only way to know what a product contains is a batch-specific certificate of analysis.

Does white kratom have more mitragynine than green?

There is no consistent evidence that it does. Mitragynine levels vary widely with season, growing region and drying, with Thai leaf studies measuring roughly 0.3% to 4.9% of dry weight.⁵ That spread dwarfs any reported colour effect. The mitragynine percentage on a COA for your batch is the figure that matters.

Which is safer, white or green kratom?

Neither colour is safer. Both are the same plant with the same risks, including dependence, withdrawal, liver injury and interactions with medicines cleared by the CYP3A enzyme.⁶⁷ Product quality matters more than colour: a verified batch COA showing low 7-OH, acceptable heavy metals and clean microbiology is the more meaningful safety check.

Sources

1. Huisman G, Menke M, Grundmann O, Schreiber R, Mason N. Examining the Psychoactive Differences between Kratom Strains. Int J Environ Res Public Health. 2023;20(14):6425. DOI: 10.3390/ijerph20146425. PMID: 37510657. pubmed.ncbi.nlm.nih.gov
2. Zhang M, Lyndon A, Kanumuri SRR, Sharma A, Pearson BJ, McCurdy CR, Chen J. Alkaloid biosynthesis in medicinal crop kratom (Mitragyna speciosa) varies with postharvest, genetic, and seasonal factors. Front Plant Sci. 2025;16:1653916. DOI: 10.3389/fpls.2025.1653916. PMID: 41090093. pubmed.ncbi.nlm.nih.gov
3. Ransden KE, Ramachandria P, Laforest LC, Kanumuri SRR, Sharma A, McCurdy CR, Nadakuduti SS. Comparative analysis of monoterpene indole alkaloid composition and genotypic variation in Thai Mitragyna speciosa. Front Plant Sci. 2026;17:1821609. DOI: 10.3389/fpls.2026.1821609. PMID: 42158609. pubmed.ncbi.nlm.nih.gov
4. Tanna RS, Nguyen JT, Hadi DL, Manwill PK, Flores-Bocanegra L, Layton ME, White JR, Cech NB, Oberlies NH, Rettie AE, Thummel KE, Paine MF. Clinical Pharmacokinetic Assessment of Kratom (Mitragyna speciosa), a Botanical Product with Opioid-like Effects, in Healthy Adult Participants. Pharmaceutics. 2022;14(3):620. DOI: 10.3390/pharmaceutics14030620. PMID: 35335999. pubmed.ncbi.nlm.nih.gov
5. Sengnon N, Vonghirundecha P, Chaichan W, Juengwatanatrakul T, Onthong J, Kitprasong P, Sriwiriyajan S, Chittrakarn S, Limsuwanchote S, Wungsintaweekul J. Seasonal and Geographic Variation in Alkaloid Content of Kratom (Mitragyna speciosa (Korth.) Havil.) from Thailand. Plants (Basel). 2023;12(4):949. DOI: 10.3390/plants12040949. PMID: 36840297. pubmed.ncbi.nlm.nih.gov
6. US Food and Drug Administration. FDA and Kratom. FDA Public Health Focus; page last updated 2 December 2025. fda.gov
7. Tanna RS, Nguyen JT, Hadi DL, Layton ME, White JR, Cech NB, Oberlies NH, Rettie AE, Thummel KE, Paine MF. Clinical Assessment of the Drug Interaction Potential of the Psychotropic Natural Product Kratom. Clin Pharmacol Ther. 2023;113(6):1315-1325. DOI: 10.1002/cpt.2891. PMID: 36924284. pubmed.ncbi.nlm.nih.gov
8. Schwensohn C, Nsubuga J, Cronquist L, Jose G, Mastel L, McCullough L, Smith L, Powell M, Booth H, Allen K, Classon A, Gieraltowski L. A Multiple-Serotype Outbreak of Salmonella Infections Linked to Kratom, United States, 2017-2018. Foodborne Pathog Dis. 2022;19(9):648-653. DOI: 10.1089/fpd.2022.0013. PMID: 35917511. pubmed.ncbi.nlm.nih.gov
9. US Food and Drug Administration. Laboratory Analysis of Kratom Products for Heavy Metals. FDA Public Health Focus (analysis of 30 kratom products for lead and nickel, 2019). fda.gov
10. Lydecker AG, Sharma A, McCurdy CR, Avery BA, Babu KM, Boyer EW. Suspected Adulteration of Commercial Kratom Products with 7-Hydroxymitragynine. J Med Toxicol. 2016;12(4):341-349. DOI: 10.1007/s13181-016-0588-y. PMID: 27752985. pubmed.ncbi.nlm.nih.gov
11. Drug Enforcement Administration. Schedules of Controlled Substance: Temporary Placement of 7-Hydroxymitragynine Above a Specified Threshold in Schedule I (notice of intent). Federal Register. 6 July 2026;91 FR 40917. Document 2026-13580. federalregister.gov
12. Drug Enforcement Administration. Schedules of Controlled Substances: Temporary Placement of Mitragynine Pseudoindoxyl, MGM-15, and MGM-16 in Schedule I (temporary scheduling order, effective 26 August 2026). Federal Register. 26 August 2026;91 FR 54948. Document 2026-17429. federalregister.gov

Editorial note: This article is for general information only and is not medical or legal advice. White and green kratom have not been evaluated by the FDA to diagnose, treat, cure or prevent any disease. Laws vary by location and change often, so verify the rules that apply where you are. Always talk to a licensed healthcare provider before use, especially if you are under 21, pregnant or nursing, taking medication, or managing a health condition.